what is the difference between semaglutide tablets and injections Weekly GLP-1 Injection vs Daily Oral: Tirzepatide – PlexusDx Experts have compared the Wegovy

You take the pill in the morning

Visceral fat reduction: 15-18% after 26-52 weeks Response rate: 69% of participants achieved 8% or greater VAT reduction Triglyceride reduction: 50 mg/dL average decrease Cholesterol ratio improvement: Significant improvement in total cholesterol to HDL ratio Liver fat reduction: Modest reductions in hepatic fat content Beyond Fat Loss: Metabolic Benefits Tesamorelin produces metabolic improvements that extend beyond simple fat reduction

Losing muscle can slow your metabolism, making it harder to maintain weight loss in the future

New delivery methods like GLP-1 patches and oral versus injectable formulations are also changing how these medications reach patients, which could indirectly affect eligibility standards as access models evolve

That means your healthcare provider will start you on a lower dose of semaglutide and gradually increase it to a higher dose over time